Related Experiment Videos
Extensive drug surveillance--a pilot study
Abstract:
The aim of this Extensive Drug Surveillance programme was to develop a system of drug monitoring suitable for detecting adverse drug reactions in hospitalised patients. The monitored field was a general medical ward in the Royal Adelaide Hospital and monitoring was carried out for a period of one month (September 1974). A total of 85 patients (45 males and 40 females) were monitored and in 14 of them adverse reactions were noted. The overall incidence of such reactions was 16.5%. A greater intake of drugs was a significant finding in patients who experienced adverse reactions. Coupled with this was the observation that patients who stayed longer in hospital had a greater number of drugs administered to them. A third finding was the higher incidence of reactions in female patients.
Insights
This study developed a drug surveillance system to detect adverse drug reactions in hospitalized patients. The system identified a 16.5% incidence of reactions, particularly in female patients with higher drug intake.
Area of Science:
- Pharmacovigilance
- Hospital Pharmacy
- Clinical Drug Monitoring
Background:
- Adverse drug reactions (ADRs) pose a significant risk to hospitalized patients.
- Effective drug surveillance systems are crucial for identifying and mitigating ADRs.
- Previous monitoring systems may not adequately capture ADRs in general hospital wards.
Purpose of the Study:
- To develop and implement an Extensive Drug Surveillance (EDS) program.
- To monitor for adverse drug reactions in a general medical ward setting.
- To evaluate the incidence and characteristics of ADRs in hospitalized patients.
Main Methods:
- A prospective drug surveillance program was conducted over one month (September 1974).
- Monitoring focused on a general medical ward at the Royal Adelaide Hospital.
- Data collected included patient demographics, drug administration, and observed adverse reactions.
Main Results:
- A total of 85 patients were monitored (45 males, 40 females).
- 14 patients experienced adverse reactions, resulting in an overall incidence of 16.5%.
- Higher drug intake, longer hospital stays, and female gender were associated with increased ADR incidence.
Conclusions:
- The developed EDS system effectively identified ADRs in a hospital setting.
- Patient factors such as drug regimen complexity and gender influence ADR risk.
- Further research is warranted to refine drug monitoring strategies and patient safety protocols.